Switchability Criteria

Switchability Criteria is a methodological framework within bioequivalence assessment that specifies the conditions under which interchangeable use of pharmaceutical products can be deemed therapeutically equivalent and safe for patient switching without adverse clinical outcomes.

21

Publications

650

Citations

68

Authors

43

Institutions

Publications per year

2017–2026

6

Authors

68

  1. TH
    Terry Hyslop

    Thomas Jefferson University, United States

    3 publications · 195 citations

    3

    h-index

  2. FH
    Francis Hsuan

    Temple University, United States

    3 publications · 149 citations

    3

    h-index

  3. WW
    Walter W. Hauck

    Thomas Jefferson University, United States

    3 publications · 203 citations

    3

    h-index

  4. PL
    P. Lees

    Royal Veterinary College, United Kingdom

    2 publications · 56 citations

    2

    h-index

  5. AB
    Alain Bousquet‐mélou

    École Nationale Vétérinaire de Toulouse, France

    2 publications · 56 citations

    2

    h-index

1–5 of 68

Venues

  1. Statistics in Medicine

    6 publications · 299 citations

    6

    h-index

  2. Clinical Pharmacokinetics

    2 publications · 56 citations

    2

    h-index

  3. International Journal of Bifurcation and Chaos

    IJBC · 2 publications · 25 citations

    2

    h-index

  4. American Journal of Health-System Pharmacy

    AJHP · 1 publications · 12 citations

    1

    h-index

  5. Nonlinear Analysis Real World Applications

    1 publications · 14 citations

    1

    h-index

1–5